Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Ecancermedicalscience|September 8, 2022
Second-line therapy in testicular germ cell tumours: results from a tertiary cancer care centre in IndiaAmit Joshi, Devanshi Kalra, Vijai Simha, et al.
Experimental and Molecular Pathology|September 7, 2018
Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformationCrismita Dmello, Sharada Sawant, Pratik Rajeev Chaudhari, et al.
Cancer Medicine|January 6, 2024
Performance of potentially inappropriate medications assessment tools in older Indian patients with cancerSharath Kumar, Renita Castelino, Abhijith Rao, et al.
Oral Oncology|April 5, 2026
Diagnostic value of MRI-based iENE assessment for predicting major and minor extranodal extension in oral tongue carcinomaNivedita Chakrabarty, Tapish Dadlani, Abhishek Mahajan, et al.
Eclinicalmedicine|April 28, 2022
Months and Severity Score (MOSES) in a Phase III trial (PARCER): A new comprehensive method for reporting adverse events in oncology clinical trialsNilesh Ranjan, Supriya Chopra, Akshay Mangaj, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Ecancermedicalscience|January 21, 2026
Long-term outcomes with non-dose dense chemotherapy for Ewing sarcoma - a follow up of the cohort treated with EFT-2001 protocolBadira Cheriyalinkal Parambil, Girish Chinnaswamy, Maya Prasad, et al.
Cancer Medicine|August 12, 2025
Rethinking Radiation Therapy for Perineural Invasion in Oral Cancer: Does More Coverage Improve Outcomes?Sarbani Ghosh Laskar, Anuj Kumar, Ashwini Adhau, et al.
JCO Global Oncology|April 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant ChemotherapyMinit Shah, Sushmita Rath, Seema Gulia, et al.
Pageof 5